通过对38例肝癌患者行介入治疗,其中经肝动脉单纯灌注化疗药物8例,30例实行肝动灌注化疗加碘化油、明胶海绵栓塞双介入治疗。2次治疗18例,3次以上治疗20例,所有患者术后症状、体征均有改善,生存期延长,治疗术后3个月、6个月、12个月生存率分别为100％,80.5％及51.6％,而且双介入治疗者明显高于单纯灌注者。 Through interventional treatment of 38 cases of liver cancer patients, 8 cases were treated with hepatic arterial infusion of chemotherapy alone, and 30 cases were treated with hepatic arterial infusion chemotherapy plus iodized oil and gelatin sponge embolization. 18 cases were treated twice and 20 cases were treated more than 3 times. All patients had improved symptoms and signs after surgery, and the survival period was prolonged. The survival rates at 3 months, 6 months, and 12 months after treatment were 100% and 80.5 respectively. % and 51.6%, and double interventional treatment was significantly higher than those who only perfusion.